Microcap Ledger

Tickers · $BEATW

HeartBeam, Inc. $BEATW

By Microcap Ledger desk · CIK 0001779372

Facts as of . Built from SEC filings and our own data. Small caps move fast; check the latest filings.

Snapshot

Exchange
Nasdaq Capital Market
Sector
Surgical & Medical Instruments & Apparatus
Headquarters
Santa Clara, CA
Fiscal year end
December 31
Shares outstanding
56,349,171 [10-Q 2026-08-13]
as of 2026-08-11

Sources: [10-K 2026-03-12]

What the company doesAI summary of filing

HeartBeam is a medical technology company that develops ambulatory cardiac monitoring solutions. Its initial product, the HeartBeam System, is an FDA-cleared, cable-free device that captures heart electrical signals in three dimensions and synthesizes them into a 12-lead ECG for arrhythmia assessment. The company generated no revenue in 2025 and is in the early commercialization stage, planning a limited market launch in early 2026 targeting concierge and preventive cardiology practices. HeartBeam makes money through sale or licensing of its devices and services, including physician portal access and on-demand cardiologist reviews, and plans to seek insurance reimbursement for broader adoption. [10-K 2026-03-12]

Segments: HeartBeam System (cable-free 12-lead ECG device), Extended wear patch monitor (in development), Smartwatch-based 12-lead ECG monitor (in development), AI-based cardiac disease detection algorithms

Financial health

From XBRL company facts (USD)
PeriodRevenueNet incomeOperating cash flowCashFiling
6 months to Jun 2026—−$9.74M −$6.95M$8.72M[10-Q 2026-08-13]
FY ended Dec 2025—−$21.02M −$13.99M$4.38M[10-K 2026-03-12]
FY ended Dec 2024—−$19.45M −$14.47M$2.38M[10-K 2026-03-12]
Quarterly cash burn
−$3.48M
Cash runway Estimate
~7.5 months

Estimate: cash at the end of the period (6 months to Jun 2026) divided by the average monthly operating cash outflow over that period. Ignores any cash raised or spent since, and any financing.

Capital structure and dilution

Summary only. How these instruments work: Dilution & financing desk.

Share count
DateShares outstandingFiling
2024-11-0526,665,470[10-Q 2024-11-07]
2025-03-1133,725,467[10-K 2025-03-13]
2025-05-0933,806,786[10-Q 2025-05-13]
2025-08-1134,311,589[10-Q 2025-08-13]
2025-11-1134,443,563[10-Q 2025-11-13]
2026-03-1141,087,871[10-K 2026-03-12]
2026-05-1155,506,835[10-Q 2026-05-13]
2026-08-1156,349,171[10-Q 2026-08-13]
Shelf registration
S-3 filed 2026-02-09; declared effective 2026-03-17 [S-3 2026-02-09]

Listing status

Current status: 1 Form 8-K Item 3.01 filing(s) in the last 24 months, most recent 2026-07-02. Item 3.01 covers delisting notices, failures to meet a listing rule and listing transfers; read the filing for which one.

DateEventDetailsDeadlineFiling
2026-07-028-K Item 3.01Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing—[8-K 2026-07-02]

More on deficiency notices and uplistings: Listing status desk.

Who owns it

Recent Form 4 transactions
DateInsiderTypeSharesPriceFiling
2026-07-24Persen Kenneth Harrygrant105,740—[4 2026-07-24]
2026-07-24Cruickshank Timgrant167,760—[4 2026-07-24]

Catalysts and calendar

Recent filings and releases
DateTypeTitle
2026-08-148-KMaterial agreement entered
2026-08-14424B5Prospectus or prospectus supplement
2026-08-1313D/ABeneficial ownership report (5%+ holder)
2026-08-1310-QQuarterly report
2026-08-068-KDirector or officer change
2026-08-038-KShareholder vote results
2026-07-028-KListing notice or transfer
2026-06-248-KDirector or officer change; Other events
2026-06-228-KDirector or officer change
2026-06-18DEF 14AProxy statement
2026-06-05PRE 14AProxy statement
2026-05-1310-QQuarterly report

Facts as of . Small caps move fast; check the latest filings.